HopeAI, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
HopeAI, Inc. - overview
Established
2023
Location
Princeton, NJ, US
Primary Industry
Healthcare IT
About
Founded in 2023 and based in New Jersey, US, HopeAI, Inc. is a provider of a medical platform for clinical trials focused on using AI to expedite the clinical development of novel therapies. Will Ma (CEO), Feifang Hu (CSO), En Xie (CTO), and Nusrat Rahman are the co-founders of the company. HopeAI, Inc.
raised venture funding from PKSHA Capital. The company’s core offering is its AI-driven platform known as Copilot, which is a tool that is designed to streamline and optimize the clinical trial process, providing clinical development teams with insightful data. Copilot reduces the time required to analyze clinical trial results, transforming complex data into actionable insights. HopeAI organizes clinical trial results and makes them accessible through natural language.
Current Investors
PKSHA Technology Capital
Primary Industry
Healthcare IT
Sub Industries
Biotechnology, Healthcare IT
Website
www.hopeai.co/
Verticals
Artificial Intelligence
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.